FDA Expedites Treatment Of Seriously Ill COVID-19 Patients With Experimental Plasma
Scientists are rolling out an old-fashioned approach they hope will help treat COVID-19. The treatment involves giving patients plasma from people who have recovered from the virus.
In an unusual move, the Food and Drug Administration today announced that is making it easier for doctors to try an experimental treatment for COVID-19 patients that uses plasma from people who had the disease and recovered.
There is scant evidence it works in people infected
